Devyser Diagnostics AB (OSTO:DVYSR) Total Liabilities : kr123.8 Mil (As of Mar. 2025)

View and export this data going back to 2021. Start your Free Trial

What is Devyser Diagnostics AB Total Liabilities?

Devyser Diagnostics AB's Total Liabilities for the quarter that ended in Mar. 2025 was kr123.8 Mil.

Devyser Diagnostics AB's quarterly Total Liabilities increased from Sep. 2024 (kr113.90 Mil) to Dec. 2024 (kr124.80 Mil) but then declined from Dec. 2024 (kr124.80 Mil) to Mar. 2025 (kr123.80 Mil).

Devyser Diagnostics AB's annual Total Liabilities increased from Dec. 2022 (kr69.20 Mil) to Dec. 2023 (kr125.00 Mil) but then declined from Dec. 2023 (kr125.00 Mil) to Dec. 2024 (kr124.80 Mil).

Devyser Diagnostics AB Total Liabilities Historical Data

The historical data trend for Devyser Diagnostics AB's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Devyser Diagnostics AB Total Liabilities Chart

Devyser Diagnostics AB Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Liabilities

Get a 7-Day Free Trial

43.58

40.18

69.20

125.00

124.80

Devyser Diagnostics AB Quarterly Data
	Dec18	Dec19	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Liabilities	Get a 7-Day Free Trial															122.10	121.90	113.90	124.80	123.80

Devyser Diagnostics AB Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Devyser Diagnostics AB's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	72.6	+	(45.4	+	6.8
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	124.8

Total Liabilities	=	Total Assets (A: Dec. 2024 )	-	Total Equity (A: Dec. 2024 )
	=	473.8	-	349
	=	124.8

Devyser Diagnostics AB's Total Liabilities for the quarter that ended in Mar. 2025 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	74	+	(43.2	+	6.6
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	123.8

Total Liabilities	=	Total Assets (Q: Mar. 2025 )	-	Total Equity (Q: Mar. 2025 )
	=	454.2	-	330.4
	=	123.8

Devyser Diagnostics AB Total Liabilities Related Terms

Thank you for viewing the detailed overview of Devyser Diagnostics AB's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Devyser Diagnostics AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Devyser Diagnostics AB (OSTO:DVYSR) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

OL0:Germany

Address

Instrumentvagen 19, Hagersten, SWE, 126 53

Website

https://www.devyser.com

Devyser Diagnostics AB develops, manufactures and sells diagnostic solutions and analysis services to clinical laboratories in more than 65 countries. The products are used for advanced genetic testing in the hereditary disease, oncology and transplant fields, to enable targeted cancer treatment, the diagnosis of a large number of genetic diseases, and transplant patient follow-up.

Devyser Diagnostics AB Headlines

No Headlines